Harmony Biosciences
HRMY
HRMY
146 hedge funds and large institutions have $1.9B invested in Harmony Biosciences in 2021 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 40 increasing their positions, 31 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
146
Holders Change
+44
Holders Change %
+43.14%
% of All Funds
2.25%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.12%
New
59
Increased
40
Reduced
31
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
$159M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
$74.6M |
| 3 |
State Street
Boston,
Massachusetts
|
$33.1M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
$65.8M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
$20.3M |
Top Sellers
| 1 |
NP
Newlight Partners
New York
|
$38.4M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$113M |
| 3 |
VP
venBio Partners
San Francisco,
California
|
$117M |
| 4 |
PA
Perceptive Advisors
New York
|
$10.2M |
| 5 |
ACM
Aisling Capital Management
New York
|
$15.2M |
